2025 Nobel Prize Could Transform Cancer and Autoimmune Care

Viviana Cetola

Reporter, Life News Today

The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell of the United States and Shimon Sakaguchi of Japan for discoveries that revealed how the immune system prevents itself from attacking the body it is designed to protect. The Nobel Assembly at Sweden's Karolinska Institute recognized the three scientists for their pioneering research on peripheral immune tolerance and regulatory T cells, discoveries that have reshaped the field of immunology and opened promising paths toward new treatments for autoimmune diseases, cancer and organ transplant rejection.

For decades, scientists have understood how the immune system identifies and destroys viruses, bacteria and other harmful pathogens. The challenge was explaining why that same powerful defense system normally does not attack healthy organs and tissues. The work of Brunkow, Ramsdell and Sakaguchi provided that answer.

"Their discoveries have been decisive for our understanding of how the immune system works and why most people do not develop severe autoimmune diseases," the Nobel Committee said in announcing the award.

At the center of the discovery are regulatory T cells, often called Tregs, a specialized group of immune cells that act as the body's natural regulators. Instead of attacking infections, these cells monitor the immune response, determining when it should continue and when it should stop. Without them, the immune system can remain active long after a threat has disappeared, causing it to attack healthy tissues.

The research unfolded over several years. In 1995, Japanese immunologist Shimon Sakaguchi challenged the long-held belief that immune tolerance developed only during the early formation of immune cells. He identified a previously unknown population of immune cells capable of suppressing excessive immune responses throughout the body. In 2001, American scientists Mary Brunkow and Fred Ramsdell discovered that mice prone to severe autoimmune disease carried mutations in a gene known as FOXP3. They later demonstrated that defects in the human version of the same gene cause IPEX syndrome, a rare but life-threatening autoimmune disorder. Two years later, Sakaguchi connected the findings by proving that the FOXP3 gene controls the development and function of regulatory T cells. Together, the discoveries established an entirely new understanding of how the immune system maintains balance. The implications extend far beyond basic science.

Researchers are now developing therapies that increase regulatory T cells to calm the immune system in patients with autoimmune diseases or to improve the success of organ transplants. At the same time, scientists are investigating ways to temporarily reduce these cells in certain cancers, where tumors can use them to avoid being detected by the immune system. Several treatments based on these discoveries are already being evaluated in clinical trials.

Autoimmune diseases occur when the immune system mistakenly identifies the body's own tissues as foreign and continues attacking them. Conditions such as Type 1 diabetes, rheumatoid arthritis and multiple sclerosis are all examples of this malfunction. Rather than viewing the immune system simply as being "overactive," researchers now understand that many autoimmune diseases result from a failure in the body's natural braking system. Regulatory T cells provide that brake. They release signaling proteins that reduce immune activity, limit the growth of overly aggressive immune cells and help restore normal immune function once an infection has been eliminated. When those regulatory mechanisms fail, often because of mutations affecting the FOXP3 gene, the immune system can remain in a constant state of alert, leading to chronic inflammation and damage to healthy tissues. The Nobel Assembly said the laureates' discoveries have laid the foundation for an entirely new field of research and accelerated the development of therapies aimed at restoring immune balance.

More than a century after the Nobel Prize in Physiology or Medicine was first awarded, this year's honor recognizes research that has fundamentally changed scientists' understanding of one of the body's most complex systems and could ultimately improve the lives of millions of people living with immune-related diseases.